Investors are cheering Astrotech Corp (ASTC) on Wednesday after its management announced an ambitious strategic pivot into space-based hardware infrastructure. According to the company's press release, its board has approved a strategic plan focused on lunar resource development to enable quantum computing and semiconductor manufacturing on the Moon.
Rheinmetall (OTCMKTS:RNMBY - Get Free Report) and Astrotech (NASDAQ: ASTC - Get Free Report) are both aerospace companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations. Insider and Institutional Ownership 24.4% of Astrotech shares are owned
| Aerospace & Defense Industry | Industrials Sector | Thomas Boone Pickens CEO | XDUS Exchange | US0464843095 ISIN |
| US Country | 30 Employees | - Last Dividend | 29 Nov 2007 Last Split | 20 Dec 1995 IPO Date |
Astrotech Corporation, previously known as SPACEHAB, Inc., rebranded in 2009 and has its roots going back to 1984. Based in Austin, Texas, the company operates on a global scale, primarily focusing on mass spectrometry, a technology that allows the analysis of the chemical composition of substances. Astrotech Corporation is recognized for its proprietary Astrotech Mass Spectrometer Technology, which demonstrates the company's significant contribution to intellectual property in the mass spectrometry field. By developing and licensing this technology, Astrotech serves various markets, including security, agriculture, and healthcare, showcasing its versatile applications.
TRACER 1000: A cutting-edge mass spectrometer-based explosive trace detector designed to replace older detectors at critical locations such as airports, cargo facilities, secured entry points, and borders. The TRACER 1000 stands out for its sensitivity and reliability, aiming to enhance existing security measures by providing rapid and accurate detection of a wide range of explosive materials.
AgLAB-1000: Developed specifically for the burgeoning hemp and cannabis market, the AgLAB-1000 mass spectrometer is a testament to Astrotech's adaptability to emerging industries. This device aids in the precise analysis of cannabis and hemp, ensuring quality and compliance with evolving regulatory standards. Its targeted applications within the agriculture sector underscore the device's importance in improving product quality and safety.
BreathTest-1000: This innovative breath analysis tool represents a significant leap forward in medical diagnostics. Designed to detect volatile organic compound metabolites in human breath, the BreathTest-1000 could revolutionize the way diseases are screened and diagnosed. By non-invasively screening for biomarkers associated with certain diseases, this device has the potential to facilitate early detection and monitoring of health conditions, thus improving patient care and outcomes.